Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation

NCT06793410 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

100

Enrollment

OTHER_GOV

Sponsor class

Conditions

Recipients of Allogeneic Stem Cell Transplantation
HPV (Human Papillomavirus)-Associated
Acute Myeloid Leukaemia
Myelodysplastic Syndrome
Diffuse Large B Cell Lymphoma (DLBCL)

Interventions

BIOLOGICAL: Early start post-transplant vaccination with Gardasil 9®
BIOLOGICAL: Late post-transplant vaccination with Gardasil 9®

Sponsor

Vastra Gotaland Region